Conference
Biosimilars Summit: Analytical Similarity, Clinical Studies and Market Entry
Biotechnology · Pharmaceuticals
Key numbers
- Editions on record
- 1first in 2017
About Biosimilars Summit: Analytical Similarity, Clinical Studies and Market Entry
Are you part of a company facing obstacles when it comes to biosimilars? Don’t let the lack of guidelines or experience with biosimilar development slow you down. Get the information you need to help develop your products from experts and colleagues at the 2nd Biosimilars summit. The summit will address: • Quality assurance from comparing the originator to the biosmiliar to ensure compatability • Potential ramifications surrounding immunogenicity that might hinder progression • Physician and patient education on the importance and advances of biosimilars • Patient selection and population for your clinical trial to gather data • Brand awareness and marketing strategies for you new biosimilar. Join us to discuss some key insights from thought leaders into the biggest challenges in the analytical and clinical phases of biosimilar drug development, from addressing current regulatory struggles, demonstrating the quality attributes needed to prove interchangeability, and successfully entering the market. For more information download the agenda: https://goo.gl/X8nUVX
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 20–22 Feb 2017 | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Biosimilars Summit: Analytical Similarity, Clinical Studies and Market Entry?
The next dates haven't been confirmed. The last edition we have on record was 20–22 Feb 2017.
Who organises it?
IQPC.